Literature DB >> 20890472

Early dementia--optimal management in general practice.

Barbara Workman1, Fiona Dickson, Sally Green.   

Abstract

BACKGROUND: The assessment and management of dementia is complex. General practitioners are often the first point of contact for people with dementia, and their families. General practitioners have a key role in providing quality primary care in terms of the identification, assessment, provision of information, referral and ongoing management.
OBJECTIVE: This article discusses the role of the GP in the diagnosis and management of people with dementia. DISCUSSION: It is important GPs are aware of the importance of early detection of dementia. Dementia is a complex condition. It develops slowly and early signs of dementia are very subtle. Difficulty in detecting the transition between normal aging and the onset of dementia and the lack of a definitive diagnostic tool often precludes early diagnosis. Evidence based recommendations are available to assist GPs in the diagnosis and ongoing management of people with dementia.

Entities:  

Mesh:

Year:  2010        PMID: 20890472

Source DB:  PubMed          Journal:  Aust Fam Physician        ISSN: 0300-8495


  3 in total

Review 1.  Effects of chronic consumption of specific fruit (berries, cherries and citrus) on cognitive health: a systematic review and meta-analysis of randomised controlled trials.

Authors:  Yueyue Wang; Crystal Haskell-Ramsay; Jose Lara Gallegos; John K Lodge
Journal:  Eur J Clin Nutr       Date:  2022-04-20       Impact factor: 4.016

2.  Diagnosing early onset dementia and then what? A frustrating system of aftercare resources.

Authors:  Z Chemali; S Schamber; Ec Tarbi; D Acar; M Avila-Urizar
Journal:  Int J Gen Med       Date:  2012-01-19

3.  Electroacupuncture for older adults with mild cognitive impairment: study protocol for a randomized controlled trial.

Authors:  Albert Wing Nang Leung; Linda Chiu Wa Lam; Andrew Ka Lun Kwan; Celia Lai Lin Tsang; Hong Wei Zhang; Yuan Qi Guo; Chuan Shan Xu
Journal:  Trials       Date:  2015-05-27       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.